Lattice Biologics Statistics

Total Valuation

LBLTF has a market cap or net worth of 128.

Market Cap	128
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

LBLTF has 128.22 million shares outstanding.

Current Share Class	104.61M
Shares Outstanding	128.22M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.00
PB Ratio	0.00
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.74

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-24.95%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-611.19%
Weighted Average Cost of Capital (WACC)	9.34%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.92
52-Week Price Change	n/a
50-Day Moving Average	0.02
200-Day Moving Average	0.04
Relative Strength Index (RSI)	41.21
Average Volume (20 Days)	14,628

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.11

Income Statement

In the last 12 months, LBLTF had revenue of 1.56 million and -951,653 in losses. Loss per share was -0.01.

Revenue	1.56M
Gross Profit	645,642
Operating Income	-615,733
Pretax Income	-951,653
Net Income	-951,653
EBITDA	-264,731
EBIT	-615,733
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	100,743
Book Value Per Share	0.00
Working Capital	-505,685

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -132,009 and capital expenditures -567,789, giving a free cash flow of -699,798.

Operating Cash Flow	-132,009
Capital Expenditures	-567,789
Free Cash Flow	-699,798
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 41.44%, with operating and profit margins of -39.52% and -61.08%.

Gross Margin	41.44%
Operating Margin	-39.52%
Pretax Margin	-61.08%
Profit Margin	-61.08%
EBITDA Margin	-16.99%
EBIT Margin	-39.52%
FCF Margin	n/a

Dividends & Yields

LBLTF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.86%
Shareholder Yield	-33.86%
Earnings Yield	-743,478.91%
FCF Yield	-546,717.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LBLTF has an Altman Z-Score of -21.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-21.04
Piotroski F-Score	3